CH Perpignan - Hopital Saint-Jean

Perpignan 66046

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Relapsed or Refractory Chronic Lymphocytic Leukemia

Studies at this site

• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia — Completed